HealthLeaders Media January 14, 2020
The commitment includes a $200 million immunotherapy-focused partnership with the University of Pittsburgh.
KEY TAKEAWAYS
– UPMC Enterprises has created five companies in translational sciences and invested in an external biotech company and more than 30 research projects.
– UPMC has invested more than $800 million, primarily in digital health solutions, which have returned more than $1.5 billion.
UPMC Enterprises said Tuesday that it will “deploy” $1 billion to develop new drugs, diagnostics and medical devices over the next four years.
“The common link among our investments will be that each has a direct and powerful impact on how we care for patients, while generating a significant financial return,” UPMC Enterprises Executive Vice President Jeanne Cunicelli said in a media...